查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1961008

髖關節重組/置換器材市場：市場洞察、競爭格局及至2034年的市場預測

Hip Reconstruction/Replacement Devices Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

髖關節重組/置換器材市場概述

  • 全球髖關節重組/置換器材市場規模預計將從 2025 年的 92.545 億美元成長到 2034 年的 149.1771 億美元，展現出強勁且持續的成長動能。
  • 全球髖關節重組和置換器材市場預計在 2026 年至 2034 年的預測期內將以 5.51% 的複合年成長率成長。
  • 由於骨骼相關疾病的日益普遍、髖關節骨折病例的不斷增加以及技術的持續進步，全球髖關節重組/置換器材市場正快速成長。骨關節炎和骨質疏鬆症等疾病推動了對有效關節修復方案的需求，而與老齡化相關的骨折病例的急劇增加進一步刺激了手術需求。同時，3D列印植入、混合固定系統和機器人輔助手術等創新技術正在提升植入的性能和手術精度。這些因素共同推動了市場擴張，並鞏固了髖關節重組/置換器械在現代整形外科醫學中的關鍵作用。
  • 髖關節重組/置換器材市場的主要企業包括 Zimmer Biomet、Stryker Corporation、Smith & Nephew、Exactech, Inc、Johnson & Johnson Services, Inc、Corin、Microport Scientific Corporation、Conformis、B. Braun Melsungen AG、Medacta International、DJO LLC、United Orthopedic Corporation、B. Braun Melsungen AG、Medacta International、DJO LLC、United Orthopedic Corporation. Limited、Surgival、Amplitude、DEDIENNE SANTE 和 Merete GmbH。
  • 由於髖部骨折和缺血性壞死的高發病率，北美預計將繼續在髖關節重組/置換器械市場中保持主導地位。醫療保健成本的上升、產品研發的進步以及該地區主要市場參與企業對創新技術的應用，預計將在未來幾年推動髖關節重組/置換器械市場的成長。
  • 根據產品類型，預計到 2025 年，全髖關節重組植入類別將佔據最大的市場佔有率。

推動髖關節重組和置換器械市場成長的因素

  • 骨骼相關疾病的增加推動髖關節重組/置換器械市場快速成長：骨關節炎、類風濕性關節炎、缺血性壞死等骨骼相關疾病的日益普遍是推動髖關節重組/置換器械需求成長的主要因素。這些慢性疾病會導致關節進行性性退化、疼痛和活動範圍受限，需要透過手術介入來恢復正常的髖關節功能。由於全球人口老化和加速肌肉骨骼劣化的生活方式因素，需要髖關節重組的患者數量正在穩步成長。這推動了對先進植入材料、微創手術和耐用假體設計的需求，從而促進了髖關節重組/置換器械市場的整體成長。
  • 主要市場參與企業產品研發活動活性化：持續的技術創新和不斷增加的研發活動正顯著推動髖關節重組和置換器械市場的發展。製造商正致力於開發具有更高生物相容性、耐用性和機械性能的新一代植入。諸如3D列印植入、混合固定系統和生物可吸收材料等創新技術，透過改善植入物的貼合度、減少磨損和降低術後併發症，正在改變手術效果。此外，數位化手術規劃工具和機器人輔助系統的整合進一步提高了植入放置的精確度。這些進步，加上監管部門的核准和產品的上市，正在持續增強全球市場的成長和滲透率。
  • 股骨骨折發生率上升：股骨骨折發生率的上升，尤其是在老年人，是推動髖關節重組/置換器械市場發展的另一個關鍵因素。骨質疏鬆和跌倒導致的老齡化性骨骼脆弱是主要原因，通常需要進行部分或全髖關節置換術。全球健康統計數據顯示，每年發生數百萬例髖關節骨折，隨著預期壽命的延長，預計這一數字將顯著增加。不斷擴大的患者群體對可靠耐用的植入解決方案產生了持續的需求，推動了骨水泥和非骨水泥固定系統的創新，並促進了全球髖關節重組/置換器械市場的擴張。

髖關節重組/置換器材市場報告細分

本髖關節重組/置換器材市場報告全面概​​述了全球髖關節重組/置換器材市場，重點分析了關鍵趨勢、成長要素、挑戰和機會。報告按產品類型（全髖關節置換系統、部分髖關節置換系統、髖關節重新置換系統、髖關節表面置換系統）、固定方式（有骨水泥/無骨水泥）、最終用戶（醫院、整形外科診所及其他）和地區進行了詳細的市場細分。本報告深入分析了北美、歐洲和亞太地區等主要市場的競爭格局、監管環境和市場動態，並詳細介紹了主要行業參與企業的概況和近期產品創新，為企業提供所需數據，以識別市場潛力、制定戰略計劃，並在快速成長的髖關節重組/置換器械市場中把握新機遇。

髖關節重組/置換裝置是專門用於恢復因關節炎、骨折或其他退化性疾病導致髖關節損傷或病變患者的活動能力和緩解疼痛的整形外科植入和器械。這些裝置包括股骨柄、髀臼杯、襯墊和固定系統等組件，它們協同工作以取代或重組天然關節結構。透過模擬正常髖關節的生物力學，這些裝置可在置換術髖關節置換術、部分髖關節置換術或重新置換置換術後提供更佳的功能、穩定性和長期耐用性。

髖重組/置換器材市場正經歷強勁成長，這主要歸因於多種相互關聯的因素，包括骨骼相關疾病的增加、髖關節骨折病例的增加以及產品研發的不斷進步。類風濕性關節炎、類風濕性關節炎和骨質疏鬆症等疾病發病率的上升，導致旨在恢復關節活動範圍和緩解疼痛的手術干預激增，從而推動了對先進植入解決方案的需求。

同時，全球髖關節骨折病例的增加，尤其是在老年族群中，由於老齡化相關的骨骼脆弱性和跌倒，進一步推動了對有效重組和置換手術的需求。為此，製造商正在加速研發，並推出創新技術，例如3D列印植入、混合固定系統和生物可吸收材料，以提高植入的耐用性、貼合度和生物相容性。數位化規劃工具和機器人輔助系統的整合也提高了手術的精確度和效果。這些趨勢共同推動了髖關節重組和置換器械的普及和全球滲透，為未來幾年持續成長創造了有利的市場環境。

最新髖關節重組/置換器材市場的市場動態和趨勢是什麼？

肌肉骨骼疾病和退化性關節疾病的日益普遍，正顯著推動全球對髖關節重組/置換裝置的需求。根據DelveInsight估計（2024年），全球平均約有3.45億人將罹患骨關節炎。其中，73%的患者年齡在55歲及以上，60%為女性。此外，同一資訊來源也指出，全球有1,350萬人患有類風濕性關節炎。髖關節重組/置換裝置對於緩解晚期關節退化性疾病患者的疼痛和恢復其活動能力至關重要。這些裝置透過外科手術植入，有助於提高患者的生活品質和功能，對於滿足日益成長的關節炎有效治療需求至關重要。

此外，預計到2050年，亞洲將佔骨質疏鬆性髖部骨折病例的50%至60%以上。同時，預計到2050年，全球髖部骨折病例將從700萬例增加到2,100萬例。全球股骨骨折病例的急劇增加凸顯了對髖關節重組/置換裝置日益成長的需求。這些裝置在應對日益增加的髖關節損傷方面發揮關鍵作用，為恢復患者的活動能力和功能提供了有效的解決方案，同時也滿足了骨折發生率上升所帶來的日益成長的需求。

主要市場參與企業活性化產品研發力度，預計也將促進髖關節置換器材市場的成長。例如，2024年2月，史賽克公司宣布推出新的關節重建技術，並對其Mako手術機器人平台進行升級。該公司也致力於減少某些髖關節置換術中對術中透視的需求。

此外，2023年8月，全球醫療技術公司史密斯醫療（Smith & Nephew）宣佈在印度推出其OR3O雙動髖關節置換系統，用於初次和重新置換髖關節置換術。與傳統方案相比，這款雙動植入採用直徑較小的股骨頭，固定在較大的聚乙烯襯墊中，從而提供更高的穩定性、更低的脫位風險和更佳的活動範圍。

因此，上述因素綜合起來預計將在預測期內推動髖關節重組/置換器械市場的整體發展。

然而，全球髖關節重組/置換器械市場成長面臨的主要限制因素是術後併發症和植入相關風險。髖關節重組或置換手術可能導致神經和血管損傷，進而引起出血、關節周圍僵硬和活動範圍受限。此外，植入植入過程中造成的神經損傷可能導致長期麻木、肌肉無力和持續性疼痛，對患者的復原和滿意度產生負面影響。這些併發症不僅影響臨床療效，還會增加再次手術和術後照護的需求，最終導致整體醫療保健成本上升。由於患者和醫療服務提供者都希望獲得更安全、更可靠、副作用更小的植入技術，這些風險對市場成長構成了重大挑戰。

髖關節重組/置換器材市場區隔分析

髖關節重組/置換器材市場 - 依產品類型（全髖關節置換系統、部分髖關節置換系統、重新置換系統、表面置換系統）、固定方式（骨水泥/非骨水泥）、最終用戶（醫院、整形外科診所、其他）、地區（北美、歐洲、亞太、其他）分類

按地區分類的髖關節重組/置換器材市場分析

北美髖關節重組與置換器材市場趨勢

預計到2025年，北美（以美國主導）將佔據全球髖關節重組/置換器械市場43%的主導佔有率，主要歸因於髖關節骨折和缺血性壞死的高發生率。未來幾年，醫療保健成本的上升、產品研發的進步以及該地區主要市場參與企業對創新技術的應用，預計將推動髖關節重組/置換器材市場的成長。

根據DelveInsight的一項分析（2024年），美國每年將有超過30,500人發生髖部骨折，其中大多數為65歲及以上的老年人，他們因在家中或社區跌倒而受傷。據估計，髖部骨折患者在骨折後的第一年將花費約40,000美元，而美國每年治療髖部骨折的總費用超過170億美元。髖關節重組/置換裝置在髖部骨折的治療中發揮著至關重要的作用，尤其是在老年族群中。這些裝置用於恢復患者的活動能力和功能，顯著促進復健並降低長期醫療保健成本。

此外，據估計，美國每年新增 20,000 至 30,000 例股骨頭缺血性壞死新患者，導致每年約有 250,000 例全髖置換術。

該地區監管機構活性化產品研發力度，將進一步擴大髖關節重組/置換器材的市場。例如，2022年3月，史賽克公司宣布推出全髖關節置換和半髖關節置換術的Insignia髖關節柄。 置換術髖關節柄的設計與史賽克公司的Mako智慧機器人平台相容，該平台搭載總髖關節 4.1軟體。這種整合使外科醫生能夠利用基於3D CT的規劃數據，精確捕捉每位患者獨特的解剖結構。

此外，該地區的主要企業，如 Zimmer、Stryker、強生服務公司和 Exactech 公司，佔據了相當大的收入佔有率，也成長要素了髖關節重組/置換設備市場的成長。

因此，上述所有因素的相互作用將為北美地區的髖關節重組/置換器械市場提供有利的成長環境。

歐洲髖關節重組/置換器材市場趨勢

受人口老化、肌肉骨骼疾病高發生率以及先進的整形外科醫療傳統等因素的推動，歐洲髖重組/置換器材市場正經歷穩定成長。德國、英國、法國和義大利等西歐國家憑藉其完善的醫療基礎設施、龐大的手術量以及先進植入的廣泛應用，仍然是主要的需求中心。該地區不斷成長的老齡人口，加上肥胖和體能活動參與度提高等生活方式因素，持續推動初次和重新置換髖關節置換手術的需求。此外，優惠的報銷政策和政府支持的醫療保健系統也提高了大多數歐洲國家的手術可及性和手術率。

技術創新持續引領歐洲市場的發展趨勢。微創手術、機器人輔助髖置換術和電腦導航系統的引入，提高了手術精確度，改善了術後效果。此外，製造商正致力於生物材料創新，擴大採用先進陶瓷、鈦合金和多孔塗層來提高骨整合和植入的耐久性。 3D列印技術和患者特異性植入設計的興起也備受關注，使得複雜重組手術能夠實現更高的個人化和生物力學動態。

此外，對研究合作、臨床證據產生和數位轉型的高度重視正在塑造市場格局。許多歐洲醫院和整形外科中心正在整合基於人工智慧的手術規劃、數據分析和結果追蹤系統，以最佳化植入性能並支援以價值為導向的醫療服務舉措。永續性也正成為關鍵策略重點，製造商正採用環保的生產流程和可回收材料，以滿足嚴格的區域環境標準。

因此，歐洲髖重組/置換器材市場正朝著更精準、個人化和永續性的方向發展。在高醫療標準、持續創新以及對數位化和機器人輔助整形外科解決方案日益重視的推動下，歐洲仍然是成熟且不斷發展的下一代髖關節置換技術中心。

髖關節重組/置換器材市場的主要企業有哪些？

以下是髖關節重組/置換器材市場的主要企業，它們合計佔據最大的市場佔有率，並主導產業趨勢：

  • Zimmer Biomet
  • Stryker Corporation
  • Smith & Nephew,
  • Exactech, Inc
  • Johnson & Johnson Services, Inc
  • Corin
  • Microport Scientific Corporation
  • Conformis
  • B. Braun Melsungen AG
  • Medacta International
  • DJO LLC
  • United Orthopedic Corporation
  • Meril Life Sciences Pvt. Ltd
  • Advin Health Care
  • Auxein Medical
  • MatOrtho Limited
  • Surgival
  • Amplitude
  • DEDIENNE SANTE
  • Merete GmbH

髖關節重組/置換器材市場的競爭格局如何？

髖關節重組/置換器材市場的競爭格局由技術創新、策略整合以及對價值醫療的日益重視共同塑造。市場高度集中，由包括史賽克（Stryker）、捷邁（Zimmer Biomet）、德普（DePuy Synthes，強生公司旗下）和史密斯醫療（Smith+Nephew）在內的主要企業主導，這些企業佔據了全球大部分收入。這些公司透過廣泛的產品系列、全球分銷網路和持續的研發投入來保持其競爭優勢。創新仍然是關鍵的差異化因素，各公司致力於基於人工智慧的術前規劃、機器人輔助手術平台以及鈦合金、陶瓷和生物可吸收複合材料等先進生物材料，以提高假體的耐用性和改善患者的治療效果。

策略聯盟和收購正在進一步重塑競爭格局，企業不斷拓展技術能力和地理覆蓋範圍，同時鞏固其在微創手術和門診髖關節手術等快速成長領域的地位。規模較小的新興企業在3D列印、特異性植入和智慧感測器義肢等細分領域進行創新，但在擴大生產規模和遵守嚴格的法規方面面臨挑戰。

此外，服務模式的競爭也正在加劇，製造商提供數據驅動的支援、數位化手術生態系統和基於績效的報銷框架，以增強客戶忠誠度。

整體而言，市場競爭格局正朝著技術整合、產品系列多元化和成本最佳化的方向演變。大型現有企業正透過創新和合作鞏固其市場主導地位，而靈活的新參與企業則在細分領域推動技術進步，共同引領髖關節重組和置換器械市場走向更加智慧、互聯和以結果為導向的未來。

髖關節重組/置換器材市場的最新趨勢

  • 2025 年 7 月，MatOrtho® 宣布其 ReCerf® 髖置換術(HRA) 獲得 CE 標誌，確認符合歐洲安全和性能標準。
  • 2025年7月，由倫敦帝國學院衍生公司Embody Orthopaedic研發的新型髖植入獲得CE認證，標誌著髖關節置換術領域的一個重要里程碑。該植入物名為H1，旨在為女性和體型較小的男性提供髖關節置換術的選擇，這些群體由於解剖結構和磨損等問題，以往通常被排除在此類治療之外。

影響分析

人工智慧驅動的創新和應用

人工智慧驅動的創新正在改變髖關節重組和置換器材市場，在整個醫療過程中提升精準度、個人化和效率。機器學習和預測分析技術分析解剖學和動態數據，從而實現針對患者的個人化植入設計，改善植入物的貼合度、對位性和長期耐用性。這種由人工智慧驅動的客製化方案可減少脫位和鬆動等併發症，促進活動能力恢復，並最大限度地減少再次手術。

在外科手術領域，人工智慧輔助規劃工具、機器人系統和電腦視覺技術透過最佳化植入放置、提供即時決策支援和標準化複雜手術流程，正在革新手術的精準度和一致性，從而縮短手術時間、減少錯誤並加快患者康復。同時，在製造業領域，透過生成式建模、預測性維護和自動化品管來簡化設計和生產流程，正在推動開發更輕、更強、生物相容性更好的植入。

從市場觀點來看，人工智慧的整合將透過改善治療效果和降低醫療成本來提升價值，從而增強製造商的競爭力。然而，高昂的實施成本、資料安全、模型透明度和監管障礙等挑戰可能會阻礙其普及。確保資料集的多樣性和公正性以及人工智慧的合乎倫理的使用對於防止治療效果差異至關重要。

未來，人工智慧與智慧生物材料和配備感測器的植入結合，將實現術後持續監測和關節健康的預測性維護。隨著檢驗和監管的成熟，人工智慧賦能的髖關節重組有望成為個人化整形外科的基礎，從而帶來更安全的手術、更好的治療效果和更高的長期療效。

美國關稅對髖關節重組/置換器材市場的影響分析：

美國對髖關節重組和置換器械徵收關稅將增加整個供應鏈的成本並壓縮利潤空間，尤其是那些依賴進口原料、專用零件（例如鈷鉻合金、客製化軸承）和成品植入的製造商。更高的進口關稅可能會增加器械和植入零件的到岸成本，從而導致產品價格上漲或製造商利潤率下降。醫院和門診手術中心的採購部門將被迫做出更嚴格的預算決策，這可能導致採購週期延長，並盡可能優先選擇國內供應商。

供應鏈中斷和回流獎勵的影響將會加劇。雖然關稅會使垂直整合或國內製造更具吸引力，並鼓勵對本地生產和積層製造進行資本投資，但這些轉變需要時間，這將推高短期內的資本和營運成本。規模較小、資金管道有限的原始設備製造商（OEM）可能受到的影響尤其嚴重。這些公司可能會將更多業務外包、進行整合或退出細分市場，這可能會降低競爭和創新的多樣性。

報銷和支付方趨勢可能會加劇這種影響。聯邦醫療保險（Medicare）、醫療補助（Medicaid）和私人保險公司對成本非常敏感，持續的價格上漲可能導致更嚴格的藥品清單、更高的基於價值的採購標準，或者迫使醫院轉向使用成本更低的植入，這可能會抑制高價高階醫療器材的銷售。相反，如果成本差異縮小，增加的「購買美國貨」獎勵和採購偏好可能會導致市場佔有率轉移到美國製造商。

監管和合規負擔與關稅效應相互作用。選擇在地化生產的製造商必須遵守FDA醫療設備註冊、品質系統和供應驗證等規定，這使得實現關稅減免既耗時又昂貴。關稅也可能促使企業進行垂直整合（從零件到成品），以避免關稅負擔，但這需要對法律規範和品質基礎設施進行投資。

潛在的緩解措施和市場應對措施包括策略採購多元化、簽訂長期供應商協議、合法進口重新分類（一種規避關稅的策略）、價格套期保值以及更多地使用國內契約製造組織（CDMO）。支付方和醫療系統可能會透過全面的價格談判和嚴格的價值評估來控制整個醫療過程的整體成本。政策制定者可以透過獎勵將生產遷回國內以及對關鍵醫療用品實行關稅豁免來抵消關稅的影響，從而保障醫療用品的可及性和創新性。

展望：短期內，關稅將推高成本，擾亂供應商運作，並擠壓中小企業生存空間。中長期來看，關稅將加速國內製造業發展與產業整合，改變競爭格局，但不會消除需求。最終影響將取決於關稅的規模和持續時間、國內產能的可用性以及相應的政策應對措施（採購規則、獎勵和豁免）。

目錄

第1章 髖關節重組/置換器材市場報告概述

2. 髖執行摘要重組/置換器材市場概要

  • 市場概覽

第3章 髖關節重組/置換器材市場關鍵因素分析

  • 髖關節重組/置換器材市場促進因素
    • 骨骼相關疾病增加
    • 產品開發活動增加
    • 髖部骨折增加
  • 髖關節重組/置換器材市場的限制與挑戰
    • 植入相關的神經和血管損傷、出血和僵硬
    • 神經損傷會導致麻木、虛弱和疼痛
  • 髖關節重組/置換器材市場機遇
    • 整合3D列印和人工智慧技術等新技術

第4章 影響分析

  • 人工智慧驅動的創新和應用
  • 美國關稅的影響分析

第5章 監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

6. 髖關節重組/置換器材市場－波特五力分析

7. 髖關節重組/置換器材市場評估

  • 依產品類型
    • 全髖關節置換術
    • 部分髖關節置換植入術
    • 髖關節重新置換植入
    • 髖關節重組植入
  • 固定
    • 水泥
    • 非水泥
  • 最終用戶
    • 醫院
    • 整形外科診所
    • 其他
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 競爭情勢

第9章Start-Ups資金籌措與投資趨勢

10. 髖關節重組/置換器材市場中的公司和產品概況

  • Stryker Corporation
  • Smith & Nephew
  • Exactech, Inc
  • Johnson & Johnson
  • Corin
  • Microport Scientific Corporation
  • Conformis
  • B. Braun Melsungen AG
  • Medacta International
  • DJO LLC
  • United Orthopedic Corporation
  • Meril Life Sciences Pvt. Ltd
  • Advin Health Care
  • Auxein Medical
  • MatOrtho Limited
  • Surgival
  • Amplitude
  • DEDIENNE SANTE
  • Merete GmbH

第11章：KOL視角

第12章計劃方法

第13章：關於 DelveInsight

第14章 免責聲明和聯絡我們

Product Code: DIMDCL0079

Hip Reconstruction/Replacement Devices Market Summary

  • The global hip reconstruction/replacement devices market is expected to increase from USD 9,254.50 million in 2025 to USD 14,917.71 million by 2034, reflecting strong and sustained growth.
  • The global hip reconstruction/replacement devices market is growing at a CAGR of 5.51% during the forecast period from 2026 to 2034.
  • The global hip reconstruction and replacement devices market is growing rapidly due to the rising prevalence of bone-related disorders, increasing hip fracture cases, and continuous technological advancements. Conditions like osteoarthritis and osteoporosis are driving the need for effective joint restoration solutions, while the surge in age-related fractures further boosts surgical demand. In parallel, innovations such as 3D-printed implants, hybrid fixation systems, and robotic-assisted procedures are enhancing implant performance and surgical precision. Together, these factors are propelling market expansion and reinforcing the critical role of hip reconstruction/replacement devices in modern orthopedic care.
  • The leading companies operating in the Hip Reconstruction/Replacement Devices market include Zimmer Biomet, Stryker Corporation, Smith & Nephew, Exactech, Inc, Johnson & Johnson Services, Inc, Corin, Microport Scientific Corporation, Conformis, B. Braun Melsungen AG, Medacta International, DJO LLC, United Orthopedic Corporation, Meril Life Sciences Pvt. Ltd, Advin Health Care, Auxein Medical, MatOrtho Limited, Surgival, Amplitude, DEDIENNE SANTE, Merete GmbH, and Others.
  • North America is expected to remain a dominant force in the hip reconstruction/replacement devices market. This is due to the high incidence of hip fractures and avascular necrosis. Escalating healthcare costs, advancements in product development, and the introduction of innovative technologies by key market players in the region are expected to drive the market for hip reconstruction/replacement devices in the forthcoming years.
  • In the product type segment of the hip reconstruction/replacement devices market, the total hip replacement implants category is estimated to account for the largest market share in 2025.

Factors Contributing to the Growth of the Hip Reconstruction/Replacement Devices Market

  • The increasing cases of bone-related disorders leading to a surge in the hip reconstruction/replacement devices market: The growing prevalence of bone-related disorders such as osteoarthritis, rheumatoid arthritis, osteoporosis, and avascular necrosis is a major factor driving the demand for hip reconstruction and replacement devices. These chronic conditions cause progressive joint degeneration, pain, and mobility loss, necessitating surgical intervention to restore normal hip function. With an aging global population and lifestyle factors contributing to musculoskeletal deterioration, the number of patients requiring hip joint reconstruction continues to rise. Consequently, the demand for advanced implant materials, minimally invasive procedures, and durable prosthetic designs is boosting the overall growth of the hip reconstruction/replacement devices market.
  • The rising product developmental activities among key market players: Ongoing technological innovations and increased research and development activities are significantly propelling the hip reconstruction/replacement devices market. Manufacturers are focusing on developing next-generation implants that offer enhanced biocompatibility, longevity, and mechanical performance. Innovations such as 3D-printed implants, hybrid fixation systems, and bioresorbable materials are transforming surgical outcomes by improving fit, reducing wear, and minimizing postoperative complications. Additionally, the integration of digital surgical planning tools and robotic-assisted systems further supports precision in implant placement. These advancements, coupled with regulatory approvals and product launches, continue to strengthen market growth and adoption globally.
  • Increasing cases of hip fractures: The rising incidence of hip fractures, particularly among the elderly population, is another key factor accelerating the hip reconstruction/replacement devices market. Age-related bone weakening due to osteoporosis and accidental falls are leading causes of such injuries, often necessitating partial or total hip replacement surgeries. According to global health estimates, millions of hip fractures occur annually, with the number expected to increase substantially as life expectancy rises. This growing patient pool drives consistent demand for reliable and durable implant solutions, spurring innovation in cemented and non-cemented fixation systems and expanding the market for hip reconstruction and replacement devices worldwide.

Hip Reconstruction/Replacement Devices Market Report Segmentation

This hip reconstruction/replacement devices market report offers a comprehensive overview of the global hip reconstruction/replacement devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (Total Hip Replacement System, Partial Hip Replacement System, Hip Revision System, and Hip Resurfacing System), Fixation (Cemented and Non-Cemented), End-User (Hospitals, Orthopedic Clinics, and Others), and Geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing hip reconstruction/replacement devices market.

The hip reconstruction/replacement devices are specialized orthopedic implants and instruments designed to restore mobility and relieve pain in patients with damaged or diseased hip joints, typically due to arthritis, fractures, or other degenerative conditions. These devices include components such as femoral stems, acetabular cups, liners, and fixation systems, which together replace or reconstruct the natural joint structure. By replicating normal hip biomechanics, they enable improved function, stability, and long-term durability following total or partial hip replacement or revision surgeries.

The hip reconstruction and replacement devices market is witnessing robust growth driven by several interrelated factors, including the increasing prevalence of bone-related disorders, rising cases of hip fractures, and ongoing advancements in product development. The growing incidence of conditions such as osteoarthritis, rheumatoid arthritis, and osteoporosis has led to a surge in surgical interventions aimed at restoring joint mobility and alleviating pain, thereby fueling demand for advanced implant solutions.

Simultaneously, the global rise in hip fractures, particularly among the elderly population due to age-related bone fragility and falls, has further amplified the need for effective reconstructive and replacement procedures. In response, manufacturers are accelerating research and development efforts to introduce innovative technologies such as 3D-printed implants, hybrid fixation systems, and bioresorbable materials that enhance implant longevity, fit, and biocompatibility. The integration of digital planning tools and robotic-assisted systems has also improved surgical precision and outcomes. Collectively, these trends are strengthening the adoption and global expansion of hip reconstruction/replacement devices, positioning the market for sustained growth in the coming years.

What are the latest Hip Reconstruction/Replacement Devices Market Dynamics and Trends?

The growing prevalence of musculoskeletal and degenerative joint diseases continues to significantly boost the demand for hip reconstruction and replacement devices worldwide. As per DelveInsight estimates (2024), approximately 345 million individuals are affected by osteoarthritis globally on average. Amongst this population, 73% of people living with osteoarthritis are older than 55 years, and 60% are female. Moreover, as per the same source, 13.5 million people are living with rheumatoid arthritis globally. Hip reconstruction and replacement devices are essential in alleviating pain and restoring mobility for individuals with advanced joint degeneration. Employed in surgical interventions, these devices help improve the quality of life and functionality, making them crucial in managing the increasing demand for effective solutions in arthritic conditions.

Additionally, estimates also suggest that more than 50-60% of all osteoporotic hip fractures will occur in Asia by the year 2050. In addition to this, it is also projected that the global incidence of hip fractures will rise from 7 to 21 million by 2050. The anticipated surge in hip fractures globally highlights a growing need for hip reconstruction and replacement devices. These devices play a vital role in managing the increasing number of hip injuries, offering effective solutions for restoring mobility and function, and addressing the rising demand driven by the higher incidence of fractures.

Increased product development activities by market key players are also slated to witness the market growth of hip replacement devices. For example, in February 2024, Stryker Corporation announced to showcase new joint-replacement technology and updates to its Mako surgical robotic platform. The company also aimed to reduce intraoperative fluoroscopy in certain hip-replacement procedures.

Additionally, in August 2023, Smith and Nephew, the global medical technology company, announced the launch of its OR3O Dual Mobility System for primary and revision hip arthroplasty in India. Compared to traditional solutions, the dual mobility implants featured a small-diameter femoral head that locked into a larger polyethylene insert, enhancing stability, reducing the risk of dislocation, and providing an improved range of motion.

Therefore, the factors stated above collectively will drive the overall hip reconstruction/replacement devices market during the forecast period.

However, the growth of the global hip reconstruction/replacement devices market faces notable restraints related to postoperative complications and implant-associated risks. Surgical procedures involving hip reconstruction or replacement carry the potential for nerve and blood vessel injuries, leading to bleeding, stiffness, and compromised mobility around the operated joint. Additionally, nerve damage during implantation can result in long-term numbness, muscle weakness, and persistent pain, adversely affecting patient recovery and satisfaction. These complications not only impact clinical outcomes but also increase the need for revision surgeries and postoperative care, thereby elevating overall healthcare costs. Such risks pose a significant challenge to market growth, as both patients and healthcare providers demand safer, more reliable implant technologies with minimal adverse effects.

Hip Reconstruction/Replacement Devices Market Segment Analysis

Hip Reconstruction/Replacement Devices Market by Product Type (Total Hip Replacement System, Partial Hip Replacement System, Hip Revision System, and Hip Resurfacing System), Fixation (Cemented and Non-Cemented), End-User (Hospitals, Orthopedic Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Hip Reconstruction/Replacement Devices Market Regional Analysis

North America Hip Reconstruction/Replacement Devices Market Trends

North America, led by the U.S., accounted for a dominant share of 43% in the global Hip Reconstruction/Replacement Devices market in 2025. This is due to the high incidence of hip fractures and avascular necrosis. Escalating healthcare costs, advancements in product development, and the introduction of innovative technologies by key market players in the region are expected to drive the market for hip reconstruction/replacement devices in the forthcoming years.

According to DelveInsight analysis (2024), annually, over 30,500 individuals in the U.S. experience a hip fracture, with the majority occurring in those aged 65 and older due to falls in the home or community. Moreover, the estimates suggest that a patient incurs costs of approx USD 40,000 in the first year after a hip fracture, with the annual expense for hip fracture care in the U.S. exceeding USD 17 billion. Hip reconstruction and replacement devices play a crucial role in managing hip fractures, especially among older adults. They are used to restore mobility and function, significantly impacting recovery and reducing long-term healthcare costs.

Additionally, the estimates reported that in the United States, avascular necrosis of the femoral head is estimated to affect between 20,000 and 30,000 new patients each year. This condition contributes to the overall number of total hip arthroplasties performed annually, which totals approximately 250,000 procedures.

Rising product development activities by regulatory bodies in the region will further boost the market for hip reconstruction/replacement devices. For example, in addition to this, in March 2022, Stryker announced the launch of the Insignia hip stem for total hip and hemiarthroplasty procedures. The Insignia stem was designed to be compatible with Stryker's Mako SmartRobotics platform, which utilizes Total Hip 4.1 software. This integration allowed surgeons to use data from a 3D, CT-based plan to capture each patient's unique anatomy.

Additionally, the presence of key players such as Zimmer, Stryker, Johnson and Johnson Services, Inc., Exactech, Inc, among others, in the region is also a driving factor for the hip reconstruction/replacement devices market as they hold significant revenue shares.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North America region in the hip reconstruction/replacement devices market.

Europe Hip Reconstruction/Replacement Devices Market Trends

The Europe hip reconstruction and replacement devices market is witnessing steady growth, supported by an aging population, high prevalence of musculoskeletal disorders, and a strong tradition of advanced orthopedic care. Western European countries such as Germany, the U.K., France, and Italy remain key demand centers due to their well-established healthcare infrastructure, high procedural volumes, and widespread adoption of technologically advanced implants. The region's growing elderly population, coupled with lifestyle factors such as obesity and increased participation in physical activities, continues to drive the need for both primary and revision hip replacement surgeries. Additionally, favorable reimbursement frameworks and government-supported healthcare systems contribute to high accessibility and procedural uptake across most European nations.

Technological advancement remains a defining trend in the European market. The adoption of minimally invasive surgical approaches, robotic-assisted hip replacement, and computer-navigated systems is enhancing procedural accuracy and improving postoperative outcomes. Moreover, manufacturers are increasingly focusing on biomaterial innovation, with growing use of advanced ceramics, titanium alloys, and porous coatings designed to enhance osseointegration and implant longevity. The emergence of 3D printing and patient-specific implant design is also gaining traction, allowing for greater customization and biomechanical precision in complex reconstructions.

The market is further shaped by a strong emphasis on research collaborations, clinical evidence generation, and digital transformation. Many hospitals and orthopedic centers in Europe are integrating AI-based surgical planning, data analytics, and outcome-tracking systems to optimize implant performance and support value-based care initiatives. Sustainability is also becoming a key strategic focus, with manufacturers adopting eco-friendly production processes and recyclable materials to meet the region's stringent environmental standards.

Hence, the Europe hip reconstruction and replacement devices market is advancing toward greater precision, personalization, and sustainability. Supported by high healthcare standards, continuous innovation, and a growing focus on digital and robotic-assisted orthopedic solutions, Europe remains a mature yet evolving hub for next-generation hip replacement technologies.

Who are the major players in the Hip Reconstruction/Replacement Devices Market?

The following are the leading companies in the hip reconstruction/replacement devices market. These companies collectively hold the largest market share and dictate industry trends.

  • Zimmer Biomet
  • Stryker Corporation
  • Smith & Nephew,
  • Exactech, Inc
  • Johnson & Johnson Services, Inc
  • Corin
  • Microport Scientific Corporation
  • Conformis
  • B. Braun Melsungen AG
  • Medacta International
  • DJO LLC
  • United Orthopedic Corporation
  • Meril Life Sciences Pvt. Ltd
  • Advin Health Care
  • Auxein Medical
  • MatOrtho Limited
  • Surgival
  • Amplitude
  • DEDIENNE SANTE
  • Merete GmbH

How is the competitive landscape shaping the Hip Reconstruction/Replacement Devices market?

The competitive landscape of the hip reconstruction and replacement devices market is shaped by a mix of technological innovation, strategic consolidation, and growing emphasis on value-based care. The market is highly concentrated, dominated by a few key players such as Stryker, Zimmer Biomet, DePuy Synthes (Johnson & Johnson), and Smith+Nephew, which collectively account for a major share of global revenue. These companies leverage extensive product portfolios, global distribution networks, and continuous R&D investment to maintain a competitive advantage. Innovation remains a key differentiator; firms are focusing on AI-driven preoperative planning, robotic-assisted surgery platforms, and advanced biomaterials such as titanium alloys, ceramics, and bioresorbable composites to improve implant longevity and patient outcomes.

Strategic partnerships and acquisitions are further reshaping competition, enabling companies to expand technological capabilities and geographic reach while enhancing their position in fast-growing segments like minimally invasive and outpatient hip procedures. Smaller and emerging players are contributing niche innovations, especially in 3D printing, patient-specific implants, and smart sensor-enabled prosthetics, but face challenges in scaling production and navigating stringent regulatory pathways.

Additionally, competition is intensifying around service models, with manufacturers offering data-driven support, digital surgical ecosystems, and outcome-based reimbursement frameworks to strengthen customer loyalty.

Overall, the market's competitive dynamics are evolving toward technology integration, portfolio diversification, and cost optimization. Large incumbents are consolidating their dominance through innovation and partnerships, while agile new entrants are driving niche advancements, collectively pushing the hip reconstruction and replacement devices market toward a more intelligent, connected, and outcomes-focused future.

Recent Developmental Activities in the Hip Reconstruction/Replacement Devices Market

  • In July 2025, MatOrtho(R) announced that the ReCerf(R) Hip Resurfacing Arthroplasty (HRA) received the CE mark, confirming compliance with European safety and performance standards.
  • In July 2025, a novel hip implant developed by spin-out Embody Orthopaedic of Imperial College London received the CE Mark, marking a significant milestone in hip arthroplasty. The device, known as the H1 implant, is designed to extend the option of hip resurfacing surgery to women and smaller-built men groups previously excluded from this treatment due to anatomical and wear-related issues.

Hip Reconstruction/Replacement Devices Market Segmentation

  • Hip Reconstruction/Replacement Devices by Component Exposure
  • Total Hip Replacement Implants
  • Partial Hip Replacement Implants
  • Hip Revision Implants
  • Hip Resurfacing Implants
  • Hip Reconstruction/Replacement Devices Application Exposure
  • Cemented
  • Non-cemented
  • Hip Reconstruction/Replacement Devices End-User Exposure
  • Hospitals
  • Orthopedic Clinics
  • Others
  • Hip Reconstruction/Replacement Devices Geography Exposure
  • North America Hip Reconstruction/Replacement Devices Market
  • United States Hip Reconstruction/Replacement Devices Market
  • Canada Hip Reconstruction/Replacement Devices Market
  • Mexico Hip Reconstruction/Replacement Devices Market
  • Europe Hip Reconstruction/Replacement Devices Market
  • United Kingdom Hip Reconstruction/Replacement Devices Market
  • Germany Hip Reconstruction/Replacement Devices Market
  • France Hip Reconstruction/Replacement Devices Market
  • Italy Hip Reconstruction/Replacement Devices Market
  • Spain Hip Reconstruction/Replacement Devices Market
  • Rest of Europe Hip Reconstruction/Replacement Devices Market
  • Asia-Pacific Hip Reconstruction/Replacement Devices Market
  • China Hip Reconstruction/Replacement Devices Market
  • Japan Hip Reconstruction/Replacement Devices Market
  • India Hip Reconstruction/Replacement Devices Market
  • Australia Hip Reconstruction/Replacement Devices Market
  • South Korea Hip Reconstruction/Replacement Devices Market
  • Rest of Asia-Pacific Hip Reconstruction/Replacement Devices Market
  • Rest of the World Hip Reconstruction/Replacement Devices Market
  • South America Hip Reconstruction/Replacement Devices Market
  • Middle East Hip Reconstruction/Replacement Devices Market
  • Africa Hip Reconstruction/Replacement Devices Market

Impact Analysis

AI-Powered Innovations and Applications:

AI-powered innovations are transforming the hip reconstruction and replacement devices market by driving precision, personalization, and efficiency across the care continuum. Machine learning and predictive analytics enable the design of patient-specific implants by analyzing anatomical and biomechanical data, improving fit, alignment, and long-term durability. These AI-driven customizations reduce complications such as dislocation or loosening, enhance mobility restoration, and minimize revision surgeries.

In surgery, AI-assisted planning tools, robotic systems, and computer vision technologies are revolutionizing accuracy and consistency. They optimize implant positioning, guide real-time decisions, and standardize complex procedures, leading to shorter operating times, fewer errors, and faster recovery. Meanwhile, in manufacturing, AI streamlines design and production through generative modeling, predictive maintenance, and automated quality control, enabling the development of lighter, stronger, and more biocompatible implants.

From a market perspective, AI integration enhances value by improving outcomes and reducing healthcare costs, strengthening competitiveness for manufacturers. However, challenges such as high implementation costs, data security, model transparency, and regulatory hurdles may slow adoption. Ensuring diverse, unbiased datasets and ethical AI use will be vital to prevent disparities in outcomes.

Looking ahead, the convergence of AI with smart biomaterials and sensor-enabled implants could enable continuous postoperative monitoring and predictive maintenance of joint health. As validation and regulation mature, AI-powered hip reconstruction is poised to become a cornerstone of personalized orthopedics, delivering safer surgeries, superior outcomes, and greater long-term efficiency.

U.S. Tariff Impact Analysis on the Hip Reconstruction/Replacement Devices Market:

U.S. tariffs on hip reconstruction and replacement devices would raise costs and squeeze margins across the supply chain, particularly for manufacturers that rely on imported raw materials, specialized components (e.g., cobalt-chromium alloys, custom bearings), or finished implants. Higher import duties increase landed cost for devices and implantable components, likely translating to higher list prices or reduced manufacturer margins. Hospital and ambulatory surgery center procurement teams would face tougher budget trade-offs, potentially slowing purchasing cycles or favoring domestic suppliers where available.

Supply-chain disruption and reshoring incentives would be amplified. Tariffs make vertically integrated or U.S.-based manufacturing more attractive, encouraging capital investment in local production and additive manufacturing, but those shifts take time and raise near-term capital and operating costs. Smaller OEMs that lack scale or capital access would be disproportionately affected. They may outsource more, consolidate, or exit niche segments, reducing competition and innovation variety.

Reimbursement and payer dynamics would magnify the impact. Medicare, Medicaid, and private insurers are cost-sensitive; persistent price increases could prompt tighter formularies, stricter value-based procurement, or pressure on hospitals to substitute lower-cost implants, compressing volumes for higher-priced premium devices. Conversely, stronger "buy American" incentives or procurement preferences could shift market share toward U.S. manufacturers if cost gaps narrow.

Regulatory and compliance burdens would interact with tariff effects. Manufacturers choosing to localize production must navigate FDA device registration, quality systems, and supply validation, adding time and expense before tariff-driven savings are realized. Tariffs may also spur increased vertical integration (component to finished device) to avoid duty exposure, but that requires regulatory oversight and investment in quality infrastructure.

Mitigation strategies and market responses are likely: strategic sourcing diversification, long-term supplier contracts, tariff engineering (reclassifying inputs where lawful), price hedging, and increased adoption of domestic contract manufacturers (CDMOs). Payers and health systems may negotiate bundled pricing or adopt stricter value assessments to contain total episode-of-care costs. Policymakers could counterbalance tariffs with incentives for onshoring or exemptions for critical medical supplies to preserve access and innovation.

Outlook: in the short term, tariffs raise costs, disrupt suppliers, and squeeze smaller players; in the medium-to-long term, they could accelerate domestic manufacturing and consolidation, shifting competitive dynamics but not eliminating demand. The ultimate effect depends on tariff magnitude, duration, availability of domestic capacity, and parallel policy responses (procurement rules, incentives, or exemptions).

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the Hip Reconstruction/Replacement Devices market report study

  • Market size analysis for the current hip reconstruction/replacement devices market size (2025), and market forecast for 8 years (2026 to 2034)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the hip reconstruction/replacement devices market.
  • Various opportunities available for the other competitors in the hip reconstruction/replacement devices market space.
  • What are the top-performing segments in 2025? How these segments will perform in 2034?
  • Which are the top-performing regions and countries in the hip reconstruction/replacement devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the hip reconstruction/replacement devices market growth in the future?

Frequently Asked Questions for the Hip Reconstruction/Replacement Devices Market

1. What is the growth rate of the hip reconstruction/replacement devices market?

  • The hip reconstruction/replacement devices market is estimated to grow at a CAGR of 5.51% during the forecast period from 2026 to 2034.

2. What is the market for hip reconstruction/replacement devices?

  • The Hip replacement devices market is expected to increase from USD 9,254.50 million in 2025 to USD 14,917.71 million by 20342, reflecting strong and sustained growth.

3. Which region has the highest share in the hip reconstruction/replacement devices market?

  • North America is expected to remain a dominant force in the hip reconstruction/replacement devices market. This can be ascribed to the high incidence of hip fractures and avascular necrosis. Escalating healthcare costs, advancements in product development, and the introduction of innovative technologies by key market players in the region are expected to drive the market for hip reconstruction/replacement devices during the forecast period.

4. What are the drivers for the hip reconstruction/replacement devices market?

  • The global hip reconstruction and replacement devices market is growing rapidly due to the rising prevalence of bone-related disorders, increasing hip fracture cases, and continuous technological advancements. Conditions like osteoarthritis and osteoporosis are driving the need for effective joint restoration solutions, while the surge in age-related fractures further boosts surgical demand. In parallel, innovations such as 3D-printed implants, hybrid fixation systems, and robotic-assisted procedures are enhancing implant performance and surgical precision. Together, these factors are propelling market expansion and reinforcing the critical role of hip reconstruction/replacement devices in modern orthopedic care.

5. Who are the key players operating in the hip reconstruction/replacement devices market?

  • Some of the key market players operating in the hip reconstruction/replacement devices market include Zimmer Biomet, Stryker Corporation, Smith & Nephew, Exactech, Inc, Johnson & Johnson Services, Inc, Corin, Microport Scientific Corporation, Conformis, B. Braun Melsungen AG, Medacta International, DJO LLC, United Orthopedic Corporation, Meril Life Sciences Pvt. Ltd, Advin Health Care, Auxein Medical, MatOrtho Limited, Surgival, Amplitude, DEDIENNE SANTE, Merete GmbH, and Others.

Table of Contents

1. Hip Reconstruction/Replacement Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Hip Reconstruction/Replacement Devices Market Executive Summary

  • 2.1 Market at Glance

3. Hip Reconstruction/Replacement Devices Market Key Factors Analysis

  • 3.1 Hip Reconstruction/Replacement Devices Market Drivers
    • 3.1.1 Increasing cases of bone-related disorders
    • 3.1.2 Rising product development activities
    • 3.1.3 Increasing cases of hip fractures
  • 3.2 Hip Reconstruction/Replacement Devices Market Restraints and Challenges
    • 3.2.1 Nerve and blood vessel injury, bleeding, and stiffness associated with implants
    • 3.2.2 Nerve damage causing numbness, weakness, and pain
  • 3.3 Hip Reconstruction/Replacement Devices Market Opportunity
    • 3.3.1 Integration of novel technologies such as 3-D printing & AI technology

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Hip Reconstruction/Replacement Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Hip Reconstruction/Replacement Devices Market Assessment

  • 7.1 By Product Type
    • 7.1.1 Total Hip Replacement Implants
    • 7.1.2 Partial Hip Replacement Implants
    • 7.1.3 Hip Revision Implants
    • 7.1.4 Hip Resurfacing Implants
  • 7.2 By Fixation
    • 7.2.1 Cemented
    • 7.2.2 Non-cemented
  • 7.3 By End-Users
    • 7.3.1 Hospitals
    • 7.3.2 Orthopedic Clinics
    • 7.3.3 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 United States Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.1.2 Canada Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.1.3 Mexico Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
    • 7.4.2 Europe
      • 7.4.2.1 France Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.2.2 Germany Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.2.3 United Kingdom Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.2.4 Italy Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.2.5 Spain Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.2.6 Rest of Europe Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 China Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.3.2 Japan Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.3.3 India Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.3.4 Australia Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.3.5 South Korea Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.3.6 Rest of Asia-Pacific Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 Middle East Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.4.2 Africa Hip Reconstruction/Replacement Devices Market Size in USD million (2023-2034)
      • 7.4.4.3 South America Hip Reconstruction/Replacement Devices Market Size In USD Million (2023-2034)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Hip Reconstruction/Replacement Devices Market Company and Product Profiles

  • 10.1 Zimmer Biomet
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 Stryker Corporation
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 Smith & Nephew
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 Exactech, Inc
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 Johnson & Johnson
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Corin
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 Microport Scientific Corporation
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Conformis
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 B. Braun Melsungen AG
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 Medacta International
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 DJO LLC
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 United Orthopedic Corporation
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy
  • 10.13 Meril Life Sciences Pvt. Ltd
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Financial Overview
    • 10.13.4 Product Listing
    • 10.13.5 Entropy
  • 10.14 Advin Health Care
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Financial Overview
    • 10.14.4 Product Listing
    • 10.14.5 Entropy
  • 10.15 Auxein Medical
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Financial Overview
    • 10.15.4 Product Listing
    • 10.15.5 Entropy
  • 10.16 MatOrtho Limited
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Financial Overview
    • 10.16.4 Product Listing
    • 10.16.5 Entropy
  • 10.17 Surgival
    • 10.17.1 Company Overview
    • 10.17.2 Company Snapshot
    • 10.17.3 Financial Overview
    • 10.17.4 Product Listing
    • 10.17.5 Entropy
  • 10.18 Amplitude
    • 10.18.1 Company Overview
    • 10.18.2 Company Snapshot
    • 10.18.3 Financial Overview
    • 10.18.4 Product Listing
    • 10.18.5 Entropy
  • 10.19 DEDIENNE SANTE
    • 10.19.1 Company Overview
    • 10.19.2 Company Snapshot
    • 10.19.3 Financial Overview
    • 10.19.4 Product Listing
    • 10.19.5 Entropy
  • 10.20 Merete GmbH
    • 10.20.1 Company Overview
    • 10.20.2 Company Snapshot
    • 10.20.3 Financial Overview
    • 10.20.4 Product Listing
    • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Hip Reconstruction/Replacement Devices Market in Global (2023-2034)
  • Table 2: Hip Reconstruction/Replacement Devices Market in Global by Product Type (2023-2034)
  • Table 3: Hip Reconstruction/Replacement Devices Market in Global by Fixation (2023-2034)
  • Table 4: Hip Reconstruction/Replacement Devices Market in Global by End-User (2023-2034)
  • Table 5: Hip Reconstruction/Replacement Devices Market in Global by Geography (2023-2034)
  • Table 6: Hip Reconstruction/Replacement Devices Market in North America (2023-2034)
  • Table 7: Hip Reconstruction/Replacement Devices Market in the United States (2023-2034)
  • Table 8: Hip Reconstruction/Replacement Devices Market in Canada (2023-2034)
  • Table 9: Hip Reconstruction/Replacement Devices Market in Mexico (2023-2034)
  • Table 10: Hip Reconstruction/Replacement Devices Market in Europe (2023-2034)
  • Table 11: Hip Reconstruction/Replacement Devices Market in France (2023-2034)
  • Table 12: Hip Reconstruction/Replacement Devices Market in Germany (2023-2034)
  • Table 13: Hip Reconstruction/Replacement Devices Market in United Kingdom (2023-2034)
  • Table 14: Hip Reconstruction/Replacement Devices Market in Italy (2023-2034)
  • Table 15: Hip Reconstruction/Replacement Devices Market in Spain (2023-2034)
  • Table 16: Hip Reconstruction/Replacement Devices Market in the Rest of Europe (2023-2034)
  • Table 17: Hip Reconstruction/Replacement Devices Market in Asia-Pacific (2023-2034)
  • Table 18: Hip Reconstruction/Replacement Devices Market in China (2023-2034)
  • Table 19: Hip Reconstruction/Replacement Devices Market in Japan (2023-2034)
  • Table 20: Hip Reconstruction/Replacement Devices Market in India (2023-2034)
  • Table 21: Hip Reconstruction/Replacement Devices Market in Australia (2023-2034)
  • Table 22: Hip Reconstruction/Replacement Devices Market in South Korea (2023-2034)
  • Table 23: Hip Reconstruction/Replacement Devices Market in Rest of Asia-Pacific (2023-2034)
  • Table 24: Hip Reconstruction/Replacement Devices Market in the Rest of the World (2023-2034)
  • Table 25: Hip Reconstruction/Replacement Devices Market in the Middle East (2023-2034)
  • Table 26: Hip Reconstruction/Replacement Devices Market in Africa (2023-2034)
  • Table 27: Hip Reconstruction/Replacement Devices Market in South America (2023-2034)
  • Table 28: Competitive Landscape
  • Table 29: Startup Funding & Investment Trends

List of Figures

Figures 1: Hip Reconstruction/Replacement Devices Market Drivers

Figures 2: Hip Reconstruction/Replacement Devices Market Restraints

Figures 3: Hip Reconstruction/Replacement Devices Market Opportunities

Figures 4: AI-Powered Innovations in Hip Reconstruction/Replacement Devices Market

Figures 5: US Tariff Impact on Hip Reconstruction/Replacement Devices Market

Figures 6: Regulatory Analysis (US, EU, Japan, China)

Figures 7: Porter's Five Forces Analysis

Figures 8: Competitive Analysis

Figures 9: Hip Reconstruction/Replacement Devices Market in Global (2023-2034)

Figures 10: Hip Reconstruction/Replacement Devices Market in Global by Product Type (2023-2034)

Figures 11: Hip Reconstruction/Replacement Devices Market in Global by Fixation (2023-2034)

Figures 12: Hip Reconstruction/Replacement Devices Market in Global by End-User (2023-2034)

Figures 13: Hip Reconstruction/Replacement Devices Market in Global by Geography (2023-2034)

Figures 14: Hip Reconstruction/Replacement Devices Market in North America (2023-2034)

Figures 15: Hip Reconstruction/Replacement Devices Market in the United States (2023-2034)

Figures 16: Hip Reconstruction/Replacement Devices Market in Canada (2023-2034)

Figures 17: Hip Reconstruction/Replacement Devices Market in Mexico (2023-2034)

Figures 18: Hip Reconstruction/Replacement Devices Market in Europe (2023-2034)

Figures 19: Hip Reconstruction/Replacement Devices Market in France (2023-2034)

Figures 20: Hip Reconstruction/Replacement Devices Market in Germany (2023-2034)

Figures 21: Hip Reconstruction/Replacement Devices Market in United Kingdom (2023-2034)

Figures 22: Hip Reconstruction/Replacement Devices Market in Italy (2023-2034)

Figures 23: Hip Reconstruction/Replacement Devices Market in Spain (2023-2034)

Figures 24: Hip Reconstruction/Replacement Devices Market in the Rest of Europe (2023-2034)

Figures 25: Hip Reconstruction/Replacement Devices Market in Asia-Pacific (2023-2034)

Figures 26: Hip Reconstruction/Replacement Devices Market in China (2023-2034)

Figures 27: Hip Reconstruction/Replacement Devices Market in Japan (2023-2034)

Figures 28: Hip Reconstruction/Replacement Devices Market in India (2023-2034)

Figures 29: Hip Reconstruction/Replacement Devices Market in Australia (2023-2034)

Figures 30: Hip Reconstruction/Replacement Devices Market in South Korea (2023-2034)

Figures 31: Hip Reconstruction/Replacement Devices Market in Rest of Asia-Pacific (2023-2034)

Figures 32: Hip Reconstruction/Replacement Devices Market in the Rest of the World (2023-2034)

Figures 33: Hip Reconstruction/Replacement Devices Market in the Middle East (2023-2034)

Figures 34: Hip Reconstruction/Replacement Devices Market in Africa (2023-2034)

Figures 35: Hip Reconstruction/Replacement Devices Market in South America (2023-2034)

Figures 36: Competitive Landscape

Figures 37: Startup Funding & Investment Trends